
Nate Edwards of Arya Consulting moderates a discussion with Elisabeth Gardiner of Tevard Biosciences and Donny Xu of the RTW Institute about the regulatory and manufacturing hurdles facing rare disease drug developers.
This application note demonstrated an early placement of our ‘in-house’ developed rheological test in the preformulation studies to select right type and amount of lubricant in the formulation, and, if necessary, the desired coating of punches.






